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AbSTrACT
background: Ultrasound-guided thrombin injection (TI) is an 
option for the treatment of femoral artery pseudoaneurysm. 
Nevertheless, the result of this technique in patients with acute 
coronary syndrome (ACS) may be compromised by the use 
of antithrombotic drugs. In addition, thrombin extravasation 
to systemic circulation could potentially cause an increase 
in thromboembolic events. Methods: Patients admitted with 
ACS who developed femoral artery pseudoaneurysm after a 
percutaneous procedure and treated by TI between January 
2007 and July 2011 were included. Clinical and laboratory 
characteristics, treatment results and complications were evalu-
ated. results: We evaluated 23 patients with mean age of 67.1 
± 14.2 years, 60.9% were women, with body mass index of 
28.4 ± 4.7 kg/m² and 52.2% were diabetics. At presentation, 
87% had non-ST elevation ACS and the remaining had ST 
elevation myocardial infarction. Of the evaluated patients, 
70% were submitted to percutaneous coronary intervention. 
All patients were receiving aspirin, 78.3% used P2Y12 inhibi-
tors and 39.1% used glycoprotein IIb/IIIa inhibitors. TI was 
successful in occluding the pseudoaneurysm in 100% of cases 
(96.7% after the first injection), without distal embolization, 
local infection or need of surgical correction. There were no 
cases of myocardial infarction, stroke or unscheduled revas-
cularization. There was one death due to cardiogenic shock 
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rESUMO
Injeção de Trombina Guiada por Ultrassom  
no Tratamento de Pseudoaneurisma da Artéria 
Femoral após Procedimento Percutâneo  
em Pacientes com Síndrome Coronária Aguda
Introdução: A injeção de trombina guiada por ultrassom (IT) é 
uma opção para o tratamento de pseudoaneurisma da artéria 
femoral. No entanto, o resultado dessa técnica em pacientes com 
síndrome coronária aguda (SCA) pode ser comprometido pelo 
uso de medicações antitrombóticas. Também, o extravasamento 
de trombina para a circulação sistêmica pode causar aumento 
de eventos tromboembólicos. Métodos: Foram selecionados 
todos os pacientes admitidos com SCA que apresentaram 
pseudoaneurisma da artéria femoral após procedimento percutâ-
neo, tratados com IT, entre janeiro de 2007 e julho de 2011. 
Características clínicas e laboratoriais, resultado do tratamento 
e complicações foram avaliados. resultados: Analisamos 23 
pacientes, com idade de 67,1 ± 14,2 anos, 60,9% eram do sexo 
feminino, com índice de massa corporal de 28,4 ± 4,7 kg/m², 
e 52,2% eram diabéticos. À apresentação, 87% tinham SCA 
sem supradesnivelamento do segmento ST e o restante, infarto 
do miocárdio com supradesnivelamento do segmento ST. Entre 
os pacientes avaliados, 70% foram submetidos a intervenção 
coronária percutânea. Todos os pacientes estavam em uso de 
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22 days after TI, on the second post-operative day after an 
elective coronary artery bypass graft surgery. Conclusions: 
Treatment of femoral artery pseudoaneurysm by TI is a safe 
and effective procedure in patients with ACS.
 
 
 
 
 
 
 
DESCrIPTOrS: Cardiac catheterization. Thrombin. Ultrasono- 
graphy, interventional. Acute coronary syndrome.
This study aimed to evaluate the clinical performance 
of ultrasound-guided TI in patients with acute coronary 
syndrome who developed femoral artery pseudoaneurysm 
after percutaneous procedure.
Methods
All patients with femoral artery pseudoaneurysm 
after diagnostic or therapeutic heart catheterisation 
due to acute coronary syndrome (unstable angina, 
acute coronary syndrome without ST-segment elevation 
[ACSWSTE], and myocardial infarction with ST-segment 
elevation [STEMI]), treated with ultrasound-guided TI at 
the Instituto do Coração of Hospital das Clínicas da 
Faculdade de Medicina of Universidade de São Paulo 
(São Paulo, SP, Brazil), from January 2007 to July 2011 
were selected through electronic medical record analysis.
The arterial sheath was removed by manual com-
pression for at least 15 minutes, six hours after the ad-
ministration of unfractionated heparin or ten to 12 hours 
after the last administration of low molecular-weight 
heparin. After a local pressure dressing was applied, the 
patient remained on bed rest, with lower-limb movement 
restriction for at least six hours after sheath removal.
The pseudoaneurysm diagnosis was attained by 
clinical examination (presence of painful, pulsatile 
hematoma, with murmur) and confirmed with Doppler 
ultrasound. The decision for pseudoaneurysm treatment 
with thrombin was made at the attending physician’s 
discretion.
All TI procedures were performed by a team of 
interventional radiology professionals at this institution. 
After thrombin administration and confirmation of flow 
absence, local pressure dressing was applied and the 
patient remained at rest for 24 hours.
Method effectiveness was assessed by procedural 
success, defined by flow absence within the pseudoa-
neurysm after TI.
ácido acetilsalicílico, 78,3% utilizaram inibidores da P2Y12 
e 39,1%, inibidores da glicoproteína IIb/IIIa. A IT foi eficaz 
em ocluir o pseudoaneurisma em 100% dos casos (96,7% 
após a primeira injeção), sem embolia distal, infecção local 
ou necessidade de correção cirúrgica em nenhum caso. Não 
houve infarto, acidente vascular cerebral ou revascularização 
não-programada. Houve um óbito por choque cardiogênico, 
22 dias após a IT, no segundo dia após cirurgia eletiva de 
revascularização miocárdica. Conclusões: O tratamento 
de pseudoaneurisma da artéria femoral com IT é um método 
seguro e eficaz em pacientes com SCA.
DESCrITOrES: Cateterismo cardíaco. Trombina. Ultrassonografia 
de intervenção. Síndrome coronariana aguda.
T he occurrence of femoral artery pseudoaneu-rysm after heart catheterisation has an incidence between 0.05% and 2%, increasing to 3% to 8% 
in therapeutic procedures, due to the use of larger 
caliber sheaths, as well as more potent antiplatelet 
and anticoagulant therapies, especially in patients with 
acute coronary syndrome.1-4 
The three main forms of treatment for this type of 
complication are surgical correction, ultrasound-guided 
compression, and thrombin injection (TI).
Traditionally, the surgical approach has been 
considered the reference standard; however, due to its 
invasive characteristic, it is associated with a higher rate 
of complications and wound infection, bleeding, and 
wound dehiscence. Moreover, it is also associated with 
a longer in-hospital stay and higher costs.5,6
In the early 1990s, ultrasound-guided compres-
sion was introduced by Fellmeth et al.7 as one of 
the first non-invasive methods for pseudoaneurysm 
correction. Its advantages are the fact that it is non-
invasive and low cost, but most of the time, prolonged 
compression is necessary to achieve success. Many 
patients do not tolerate it due to the pain, and it 
is less effec tive, especially in the context of acute 
coronary syndromes.8,9
Recently, TI has become the method of choice in 
the treatment of this complication.10 Several studies, 
both Brazilian and international, have shown high 
success rates when using thrombin for femoral artery 
pseudoaneurysm correction.11-15 However, few data 
are currently available on the safety and efficacy of 
local thrombin use in patients with acute coronary 
syndrome. In this population, it is speculated that the 
frequent use of anticoagulants and antiplatelet agents 
could reduce the technique effectiveness. Conversely, 
any thrombin extravasation into systemic circulation 
could determine an increase in adverse events in this 
subgroup of patients at higher atherothrombotic risk.
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The presence of complications during hospitalisation 
was assessed for the safety analysis, and was defined 
by distal embolism in the treated limb, local infection, 
need for surgical correction, need for transfusions, 
acute myocardial infarction, stroke, new unplanned 
revascularisation after the index procedure, and death.
Data on clinical, laboratory characteristics, medica-
tions used, effectiveness, and safety of the procedure 
were collected in electronic medical records.
Results
Of the 31 patients who developed pseudoaneu-
rysm of the femoral artery after catheterisation and/or 
percutaneous coronary intervention and were treated 
by ultrasound-guided TI, 23 had a diagnosis of acute 
coronary syndrome and were considered for the analysis.
The majority were female (60.9%), aged 67.1 ± 14.2 
years (32.6 years to 92.8 years), with body mass index 
= 28.4 ± 4.7 kg/m2. Systemic arterial hypertension was 
present in 91.3% of the patients, diabetes in 52.2%, 
17.4% were smokers, and 30.4% had heart failure. A 
third of the population had undergone previous per-
cutaneous coronary intervention and 8.7% had been 
submitted to myocardial revascularisation.
Hemoglobin and hematocrit values at the time of 
the percutaneous procedure were 12.4 ± 2.1 mg/dL 
and 37.9 ± 6.3%, respectively. Mean creatinine clear-
ance, calculated by the Cockroft and Gault formula, 
was 62.1 ± 34.5 mL/min. All patients were receiving 
acetylsalicylic acid, 78.3% used P2Y12 inhibitors, 39.1% 
used glycoprotein IIb/IIIa inhibitors, 65.2% used low 
molecular weight heparin, and 17.4% used unfractionated 
heparin. Only one patient (4.3%) received thrombolytic 
therapy (Table 1).
Regarding the clinical picture, 87% of patients 
had a diagnosis of unstable angina or ACSWSTE, and 
the remainder had a diagnosis of STEMI. Diagnostic 
catheterisation was performed in 30.4% and therapeutic 
procedure in 69.6% of cases. The 7F sheath was used 
in 73.9% of procedures and 6F in the remainder.
The mean time from the percutaneous procedure to 
the pseudoaneurysm diagnosis was 2.7 ± 2.5 days (me-
dian = 2 days), and until the ultrasound was performed, 
3.2 ± 0.8 days. Pseudoaneurysm neck size ranged from 
0.2 cm to 3.7 cm (mean 0.9 ± 1 cm), and the largest 
diameter ranged from 1.3 cm to 6 cm (mean 2.7 ± 1.8 
cm); they were multiloculated in 17.4% of patients.
Procedural success was achieved in 96.7% of 
patients with the first TI and in 100% with the second 
procedure (performed 48 hours after the first attempt). 
Most patients (78.3%) were receiving dual antiplatelet 
therapy and more than half (56.5%) used prophylac-
tic heparin during the procedure to repair the pseu-
doaneurysm. There were no reports of distal embolic 
complications, allergic reactions, local infection, need 
for surgical correction, need for blood products or acute 
myocardial infarction, stroke, and new revascularisation 
after the index procedure. 
There was one death among the study population 
due to cardiogenic shock, on the second postopera-
tive day after elective myocardial revascularisation, 22 
days after TI.
Table 1 
Clinical and laboratory characteristics of patients
n = 23
Clinical characteristics
Male gender, n (%) 9 (39,1)
Age, years 67.1 ± 14.2
Body mass index, kg/m2 28.4 ± 4.7
Systemic arterial hypertension, n (%) 21 (91.3)
Diabetes mellitus, n (%) 12 (52.2)
Dyslipidaemia, n (%) 17 (73.9)
Current smoking, n (%) 4 (17.4)
Previous infarction, n (%) 5 (21.7)
Heart failure, n (%) 7 (30.4)
Previous percutaneous coronary 
intervention, n (%)
8 (34.8)
Myocardial revascularisation, n (%) 2 (8.7)
Laboratory characteristics
Creatinine clearance, mL/min 62.1 ± 34.5
Hemoglobin, mg/dL 12.4 ± 2.1
Hematocrit, % 37.9 ± 6.3
Clinical picture
Acute coronary syndrome without 
ST-segment elevation
20 (87)
Myocardial infraction with  
ST-segment elevation
3 (13)
Periprocedural drug therapy, n (%)
Acetylsalicylic acid 23 (100)
P2Y12 inhibitors 18 (78.3)
Glycoprotein IIb/IIIa inhibitors 9 (39.1)
Low molecular-weight heparin 15 (65.2)
Unfractionated heparin 4 (17.4)
Thrombolytic therapy 1 (4.3)
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with thrombin use was 97%24 In the present study, 
in which 78.3% of patients used dual antiplatelet 
therapy and 56.5% used associated prophylactic use 
of heparin at the time of treatment with thrombin, 
the success rate was 100%. 
However, most studies did not specify the number 
of patients with acute coronary syndrome submit-
ted to TI for pseudoaneurysm repair. In a Brazilian 
study of 15 patients treated with TI, all successful 
procedures, ten had a diagnosis of acute coronary 
syndrome at admission.14 To date, there have been 
no studies evaluating the use of TI only in patients 
with acute coronary syndrome.
Although rare, the procedure is not free of com-
plications. In a multicenter study in Germany with 
595 patients, the incidence of thrombus formation in 
the femoral artery after TI was 0.5%, with deep vein 
thrombosis reported in 0.5%, and pulmonary throm-
boembolism in 0.2% of the population.12 Ohlow et 
al.25 reported a case of distal limb ischemia after TI 
that progressed, requiring amputation of the affected 
limb. There were no reports of complications in the 
patients treated with thrombin at the present service. 
There was only one death due to cardiogenic shock 
after elective coronary artery bypass grafting, with no 
causal association with TI.
The present study demonstrated the effectiveness 
and safety of ultrasound-guided TI for the treatment of 
femoral artery pseudoaneurysm in patients with acute 
coronary syndrome. Success was achieved in 100% of 
cases, regardless of the pseudoaneurysm complexity 
and antiplatelet agent use. Additionally, there were no 
complications related to the use of this therapy.
study limitations
This is a pioneering study on the results of TI in the 
treatment of femoral artery pseudoaneurysm in patients 
with acute coronary syndrome. However, its observa-
tional nature, without a control group for comparison 
purposes, as well as the small number of patients does 
not allow the drawing of definitive and comprehensive 
conclusions on the subject; randomized trials with larger 
numbers of patients are required.
ConClusions
The present data suggest that ultrasound-guided 
TI is a safe and effective method for the treatment of 
femoral artery pseudoaneurysm occurring after diagnos-
tic or therapeutic heart catheterisation in patients with 
acute coronary syndrome.
ConfliCt of inteRest
The authors declare no conflicts of interest.
disCussion
Pseudoaneurysm after percutaneous heart proce-
dures is one of the most common vascular complica-
tions. The main risk factors for its occurrence are age 
> 65 years, hypertension, obesity, peripheral arterial 
disease, large calibre sheaths, and use of antiplatelet 
and anticoagulant agents.10 In the present sample, the 
mean age was 67.1 years; 91.3% were hypertensive; 
73.9% used 7F sheaths, and 69.6% were receiving 
dual antiplatelet therapy associated with heparin at a 
therapeutic dose. 
Until 1990, the only available treatment for pseu-
doaneurysm was surgical correction. Although very effec-
tive, this procedure can present several complications. 
San Norberto García et al.16 studied 79 patients who 
underwent surgery for pseudoaneurysm repair. In this 
study, 71% of patients had some type of complication 
within 30 days; need for blood transfusion was the most 
frequent (53%), followed by infection (19%), and wound 
dehiscence (12.7%). The mortality related to surgery was 
3.8%. The use of antiplatelet or anticoagulant therapy 
after cardiac catheterisation was an independent risk 
factor for increased postoperative morbidity.16
In 1991, Fellmeth et al.7 described the treatment 
of a pseudoaneurysm by ultrasound-guided compres-
sion. This method has success rates between 75% 
and 98% and low complication rates.17,18 However, in 
most cases, it is a lengthy and painful procedure, and 
approximately 80% of cases require 60 minutes of 
compression.8 Moreover, in patients using antiplatelet 
and anticoagulant agents, pseudoaneurysm recurrence 
rates can reach up to 30%.19
Ultrasound-guided TI for the treatment of pseudoan-
eurysm gained prominence after the publications by Liau 
et al.20 and Kang et al.,21 with success rates of 100% 
and 95%, respectively. Subsequently, several studies 
in the literature reported success rates between 93% 
and 100%.11-15 When compared to ultrasound-guided 
compression, TI had a higher success rate (100% vs. 
87%; P < 0.05) with lower hospital cost.22 Krüger et 
al.11 also observed that the success rates were higher 
with simple pseudoaneurysms, when compared to the 
rates of multiloculated pseudoaneurysms (97% vs. 61%). 
However, in the present population, in which 17.5% 
of pseudoaneurysms were multiloculated, the success 
rate was 100%, regardless of the pseudoaneurysm 
characteristics.
TI in patients using antiplatelet and anticoagu-
lant agents was also evaluated in some studies. The 
failure rate is higher in patients with concomitant 
use of antiplatelet and anticoagulant agents (6.3% 
vs. 1.3%; P = 0.026).12 In a study of 30 patients, of 
whom 18 were anticoagulated, the success rate was 
100%.23 In another study of 274 patients using anti-
platelet and/or anticoagulant agents, the success rate 
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